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The participation of different cell types in reactions
of cellular hypersensitivity is well established (1). De
layed hypersensitivity, autoimmunity, homograft rejection,
certain allergic manifestations, immunologic responses to
cancer cells, and defense against intracellular bacteria,
viruses, fungi, and parasites are included among the immuno
logic events in which these cells take part. The cells in
volved are mainly lymphocytes, woich become sensitized to
antigens through contact, and macrophages, which use their
phagocytic property to attack, destroy, and sequester auto
logous or foreign substances. With the recognition that
more than one cell type was connected with these events, it
became necessary to establish the means of communication be
tween them. It is becoming clear that cell-free factors
produced by the sensitized lymphocytes subsequent to stimula
tion by specific antigen can involve macrophages as well as
other cell types (2), It is, therefore, of interest to de
termine whether lymphocytes can have an effect on polymor
phonuclear leukocytes. This present study investigates the
communication between these cell types by using lysozyme
production and glucose-1-l^C oxidation as indicators of
polymorphonuclear leukocyte stimulation.
In studying tae various factors already described,
experimenters have generally started with lymphocytes derived
v
from an individual having cellular hypersensitivity to a
particular antigen (3). The lymphocytes were stimulated
in vitro by incubating the cells with that antigen for a
given time, usually 21+ hours. The production of the vari
ous factors was usually highly specific in that lymphocytes
produced them in vitro only against the antigen with which
sensitization of the lymphocytes was accomplished in vivo*
Old tuberculin has been commonly used as the antigen and
was chosen as such for this study. However, it has been
recently noted that certain mitogenic agents have the abili
ty to stimulate lymphocytes nonspecif ically with the produc
tion of active factors (1+). Phytohemagglutinin is such an
agent and was also used in this investigation.
In relating the results of this study, it is the pur
pose of this thesis:
1. to report that human sensitized lymphocytes
exposed to tuberculin have a stimulatory effect
on polymorphonuclear leukocytes as indicated by
the latter* s increased glucose-1- ^ oxidation
and lysozyme production;
2. to establish time factors involved in this event;
3. to report similar results using lymphocytes non
specif ically stimulated by phytohemagglutinin;




REVIEW 0? LITE- .-WEE
A review was ma^e of asoects of the following four
areas related to the work presented in this thesis:
ohytohemagglutinin, tubercle bacillus antigen, lysozyme,
and glucose metabolism through the hexose monooaosphate
shunt.
Phytohemagglutinin
Phytohemagglutinin (PHA) is a saline extract derived
from beans of the genus Phaseolus. Goddard and Mendel (5),
in 1929, described a method for the preparation of PHA from
navy beans (Phaseolus communis). The active substance was
a protein with the characteristics of album! n. In 1909,
Wienhaus (6) partially purified proteins from red kidney
beans (Phaseolus vulgaris) and speculated that this protein
was an albumin. In 1955, Osgood and Rigas (7) completed
the purification. The final products we'-e a mucoprotein
(MPHA) and a protein (PPHA). The mucoprotein behaved as a
homogeneous substance by electroohoretic analysis over the
pH range 5.8 to 8.6. Below pH 5.8, it dissociated into a
protein phytohemagglutinin and an inactive polysacchariie .
This mucoprotein contained 6.5> nitrogen, ^d.l\.% total re
ducing substances estimated as glucose, and ws he3t-labile
and very soluble in distilled water. The protein behaved
as a homogeneous substance by electrophoresis over the pH
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range 2.0 to 8.0 and its isoelectric ooint was 6.5. The
nitrogen content of this protein >-as lk.t>, and the content
of its total reducing substances was 3Ul. It was a heat--
labile euglobulin, insoluble in distilled water, but very
soluble in saline or buffer solutions. This phytohemagglu
tinin, in either the mucoprotein or in the protein form, was
a non-toxic, powerful hemagglutinin of human, horse, pig,
dog, cat, rabbit, chicken, and frog erythrocytes.
The hemagglutinating properties of PHA were discov
ered by Landsteiner (3) in the early 1900's. This erythro-
agglutinating property can be removed by repeated absoprtion
with red blood cells. Perera and Frumin (9) demonstrated
that hemagglutination by the extract of the fava bean was
inhibited by 5^ d-glucose or maltose but not by 5^ d-galac-
tose or lactose. Borberg et al (10) found that N-acetyl-D-
galactosamine inhibited hemagglutination induced by PHA.
It was not until 1959 that Hungerford et al (11) de
scribed the mitogenic and blastoger.ic properties of PHA.
They found that this material induced transformation of small
lymphocytes in human peripheral blood into large primitive
cells, which were capable of undergoing division. The dis
covery that a large number of cells in mitosis could be ob
tained by incubating peripheral leukocytes with PHA was of
great importance in the field of cytogenetics since it pro
vided a simple and reproducible method for chromosome analy
sis. These findings stimulated further attempts to separate
the various active constituents of PHA. Barkhan and 3allas(l2)
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showed that the agglutinating activity of PHA could be re
moved by absorption with red blood cells without a concomi
tant loss of mitogenic activity, which suggests that the
mitogenic and agglutinating activities are possessed by
different entities. The presence of at least two distinct
mitogens in PHA was suggested by Richter and Naspitz (13) who
observed a difference in reactivity of human peripheral
lymphocytes to the various PHA preparations tested.
PHA also has the property of agglutinating white
blood cells iri vitro. The addition of PHA to cultures of
leukocytes results in many clumps of cells by 72 hours of
culture. This leukoagglutinating property can be removed
by absorption with white blood cells. Borberg e_t al ( lU )
demonstrated that N-acetyl-D-galactosamine inhibited leuko-
agglutination by PHA without affecting the blastogenic and
mitogenic activities of PHA. The blastogenic and mitogenic
properties of PHA are the most important ones because they
provide a method for the in vitro study of cellular enlarge
ment and division, and demonstrate that the small lymphocyte
is not a "dead end" cell.
A discussion of the effect of PHA on the carbohydrate
metabolism of lymphocytes is appropriate. Quaglino and
Cowling (15) and Gough and Elves (16) showed by the PAS-
reaction that there is a marked accumulation of glycogen in
the small lymphocyte and intermediate cells after 2k hours
of culture with PHA. The content of this substance decreased
in the later stages of transformation, and only rarely were
k
blast cells found which contained blocks of PAS positive
material. This suggests that the cells obtain some of
their energy for transformation from glycolysis. This in
terpretation is supported by the findings of Cooper e_t _al
(17) who found a high rate of lactate production in PHA
stimulated lymphocytes which indicated a high rate of gly
colysis. In addition, Pachman (13) observed an increase in
?lucose and oxygen consumption and lactic acid production
during 2h ho'jrs of culture of ecuine peripheral lymphocytes
with PHA. (See Chapter U for discussion of role of hexose
monophosphate shunt in lymphocytes.)
The metabolism of PHA in i_n vitro leukocyte cultures
with respect to the fate of the mitogen during the three day
blastogenic response was investigated by Naspitz and Richter
(19). They demonstrated that incubation of tne leukocytes
with PHA for only 5 minutes followed by incubation for 72
hours in medium devoid of PHA wa3 sufficient to initiate
mitosis and blastogenesis . However, the mini-rial incubation
time with PHA recuired to induce maximum blastogenesis was
6 hours. It was also demonstrated that the mitogen is bound
to cells in culture and the findings suggest that this cell-
bound mitogen is not degraded during the three day incubation
peri od .
There is still much debate about the mechanism where
by PHA induces blastogenesis and mitosis on normal lympho
cytes in tissue culture despite a large number of studies in
this area. Immunological and nonimmunological bases for PHA
5
action have been proposed.
Evidence in favor of an immunologic basis of rHA
action is as follows. The morphology of the blast cells
obtained after PHA stimulation is very similar, both by
light (20, 21, 22, 23) and by electon microscopy (2U, 25,
26, 27), to that of blast cells induced as a conseouence
of incubation with specific antigens. Moreover, blast
cells induced by PHA are capable of synthesizing gamma
globulin (28, 29, 30, 3D similar to cells stimulated by
antigen i_n vitro. In several human diseased states, a good
correlation between impaired delayed hypersensitivity In vivo
and depressed In vitro transformation of lymphocytes with
PHA was found (32, 33), which suggests that PHA is mea
suring the immunocompetence of the lymphocytes.
The evidence for the non-immunologic action of PHA
is as follows. In PHA stimulated cultures, the percentage
of transformed cells is 70-90^ apter three days of incuba
tion, whereas in antigen stimulated cultures, only 5-30^
of the cells are transformed after 7-10 days of culture ( 3k )
No transformation has been observed after only 3 days of cul
ture with s pecific antigen. Furthermore, the i_n vitro trans
formation with PHA does not require the presence of macro
phages (35* 36), whereas they are necessary for the antigen-
induced blastogenic response (37, 38, 39). In addition to
lymphocytes, PHA can stimulate epithelial cells in the skin
(k0), free-living amoeba (kD> and non-lymphoid lines(k2).
<-.
Tubercle bacillus antigen
Koch observed in lq-90 that viable tubercle bacilli
incubated subcutaneously into guinea pigs evoke a much more
intense inflammatory reaction in previously infected than in
uninfected animals. Since a similar result was obtained with
killed tubercle bacilli, he was led to examine bacterial ex
tracts and found that filtrates of cultures of Vycobac terium
tuberculosis were also effective. Injected in non-toxic
amounts, they elicited after many hours an inflammatory re
action in tuberculous but not in normal animaDs.. After con
centration by boiling and removal of bacterial debris, the -cul
ture filtrate was called tuberculin (k3 )
Old tuberculin ( OT ) today is prepa-ed by autoclaving
or boiling a culture of tubercle bacilli, concentrating it
10-fold on a steam bath, filtering off the debris, and adding
glycerol as a preservative. In this Impure product, the
active constituent is a protein remarkable for its heat sta
bility. After being autoclaved, it remains soluble and re
tains specific determinants of the orotein in the infecting
bacilli. Stock solutions retain full potency for years
when stored at 5C . (kk .
A sl'ghtly more refined tuberculin, called "purified
protein derivative (PPD), is now in use. It is prepared by
growing M. tuberculosis in a simple synthetic medium, auto
claving, removing debris by filtration, concentrating the
filtrate by ultrafiltration, and precipitating several times
with 50/o saturated ammonium sulfate. The product is a mix-
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ture of small proteins (average '-T.W. 10,000), together
with traces of nucleic acid and polysaccharides (k5)-
The lipids and waxes in the tubercle bacillus were
felt by Raffel and Forney (k6) to constitute the adjuvant.
According to Raffel e_t a_l (k7), it is bacause of the presence
of such adjuvants that tuberculous guinea pigs develop a de
layed type as well as the immediate type of hypersensitivity
following sensitization with egg white, whereas nontubercu-
lous guinea oigs, similarly injected with egg white, devel
op only the anaphylactic type of reaction. This "immediate"
reaction is accompanied by a whealing type of skin reaction
to egg white. As demonstrated by Dienes (kS) if the guinea
pig receives antigen like egg white in combination w ith par
affin oil and killed acid-fast bacilli (complete adjuvant),
delayed hypersensitivity develops and the skin reaction to
ern- white is of the delayed type. ^he method of administra
tion of anti-en bears an important role. The delayed tuber
culin response is obtained when the antigen-adjuvant mixture
is given intramuscularly, intraperitoneally , or intradermal-
ly but not intravenously (k9).
Lymphocytes play an important role in mediating the
delayed tuberculin response. Chase (50) demonstrated that
tuberculin hypersensitivity cannot be transferred from a
sensitized guinea pig to a normal guinea pig skin by means
of the host's serum, but that it is possible to transfer
tuberculin sensitivity with cells from hypersensitive guinea
pigs to normal guinea pigs. Lymphocytes are involved in this
a
type of transfer. Sensitivity may be transferred with cells
obtained from the lymph nodes or spleen o^ the sensitized
donor (51). The cellular passive transfer of tuberculin
sensitivity can be demonstrated when labeled cells are used.
A number of these cells appear at the local site of the ??D
reaction, although according to some, they are in the minori
ty since the host also supplies similar cells (52). This
type of transferred delayed sensitivity in man lasts for one
or two years. The degree of sensitivity tnus transferred is
determined by the ssnsitivity of the donor and the amount of
cells transf erred ,( 53 )
The nature of the factor wnich is transferred by cells
is not completely known. The transfer factor which resides
in the lymphocyte is not to be found, at least in man ( 5k )
in the DNA or RNA in the cells. The evidence suggests that
the transferred factor in not antigen, because sensitization
develops too cuickly for it to ba due to antigenic stimula
tion, nor is it antibody for no antibody is detectable in
cell extracts ( 55). Jeter e_t a_l (56) have analyzed leukocyte
extracts from guinea pigs hypersensitive to tuberculin.
They suggest that this factor is most likely a dialyzaole non
protein substance, that has a molecular weight of about
10,000 and resists RNAase treatment. It may be lyophilized
without undergoing any change. Additional transf er of tuber
culin sensitivity can be made with cells obtained from reci
pients previously sensitized by cell transfer (57). However,
such secondary transfer is usually not very strong. The
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addition in vitro of tuberculin to leukocytes obtained from
a PPD positive donor yields the transfer factor in the super-
nate (58). This factor may be separated from viable human
cells and still be active on transfer.
As stated previously (see Phytohemagglutinin), in lQt0,
PHA was shown to stimulate both mitoses and formation of
blast-like cells in cultures of normal human lymphocytes.
Soon after this observation was made, it was found that lym
phocytes could also be stimulated to divide by antigens to
which the individual was sensitive. Pearmain e_t _al (59)
substituted tuberculin for PHA in peripheral Plood leuko
cyte culture from persons sensitized to tuberculin, and ob
served a marked phase of mitosis. Schrek (60) found that
PHA and PDD produced similar effects on human lymphocytes.
Both reagents stimulated mitotic activity and the formation
of larpe blast-like cells. Coul3on and Chalmers (61) also
demonstrated blastogenesis when pDD was incubated with a
highly purified suspension of small lymphocytes obtained from
D?D positive patients.
Schrek and Stefani (62) reported that only 10r- of the
cells in cultures of human peripheral lymphocytes survived
six days after 75 r irra3iation. On the other hand, PHa-
treated suspensions irradiated with 75 to 2k00 r survived.
This protection to x-irradiation afforded by PHA i_n vitro
appeared at first to be a unique property not possessed by
antigens in general. However, it was later noted by Stefani
(63) that old tuberculin is also capable of imparting radio-
1C
protection when incubated with lymphocytes obtained from
PPD positive patients but not when incubated with cells of
PPD negative patients. He observed a relation between
old tuberculin concentration, blastoid transformation,
and radioprotection, and postulated that the radioprotective
effect of old tuberculin had an immunoloe-ic basis.
Rich and Lewis (6k) were the first to describe that
cells from snleens and lymoh nodes of tuberculin sensitive
animals showed poor migration in the presince of tuberculin.
Later, George and Vaughan (65) studied the migration of
guinea pig peritoneal exudate cells out of capillary tubes
and showed that the inhibition of migration by tuberculin
or egg albumin paralleled delayed skin reactivity to these
antigens. Using this capillary tube technique, David e_t al
(66) showed that as few as 2.5"' of peritoneal cells from
sensitive guinea pigs mixed with normal cells caused inhi
bition of the whole population and that the sensitive cells
must be viable. Inhibition does not occur if the protein
synthesis of the cells is blocked by puromycin (67). Peri
toneal exudate consists mainly of macrophages with a minority
of lymphocytes and polymorphonuclear leukocytes. 31oom and
3ennett (68) removed the lymphocytes by tissue culture methods
and showed that the remaining cells werp no longer inhibited
by antigen, but that the re-addition of even a small amount
(0.6;o) of peritoneal lymphocytes from sensitive animals re
sulted in migration inhibition. It was found that sensitive
lymphocytes interacting with specific antigen produce a sol-
11
uble
, nondialyzable material that mediates the inhibition of
macrophage migration (69, 70). Kostiala (71) found that
sensitivity to tuberculoorote in in '-"*uinea pigs sensitized
with killed tubercle bacilli in adjuvant lasts at least one
gear as determined by peritoneal cell migration inhibition.
Lysozyme
Lysozyme was first described in 1922 by Sir Alexander
Fleming (72). He also discovered a gram positive coccus,
Micrococcus lysodeikticus, which was extremely sensitive to
enzymatic lysis, and used it to develop an assay for lyso
zyme. Since then, many substances (73, 7k > 75) capable of lysing
Micrococcus lysodeikticus have been included under the name
"lysozyme". In general, a lysozyme is a low molecular weight
(about 15,000) basic protein which is stable at acid pH but
unstable at alkaline pH. It can resist boiling in glacial
acetic acid for several minutes. Lysis of Micrococcus
lysodeikticus must yield the appropriate degradation products
which can be detected by reagents for reducing sugars and
N-acetyL-hexosamines which are derived from glucosamine and
muramic acid. Highly purified lysozyme was first prepared by
Alderton (76) and Fevold (77) who adsorbed lysozyme on
Bentonite, washed it with buffered phosphate and pyridine
solutions to remove other proteins, and removed it from the
Bentonite in acid pyridine solution. Osserman and Lawler
(78) applied this technique to lysozyme of human origin.
The relationship between leukocytes and lysozyme was
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also first observed by Fleming (79) when he noted that in
fected urine and pus from abscesses contained large amounts
of lysozyme. Flanagan and Lionetti (8D) were the first to
present quantitative data on the distribution of lyaozyme in
plasma and the formed elements of the blood. They found no
significant lysozyme activity in red blood cells or platelets.
Although saline washings of leukocytes had very little enzy
matic activity, several times as much enzyme was released when
these cells were frozen and thawed. However, no activity was
found in lymphocytes alone. Finch et al ( 8l ) found no strong re
lationship between human serum lysozyme and total white blood
count, but did observe a significant correlation between
lysozyme and granulocyte count. No conclusive relationship
existed between the fifty highest and the fifty lowest abso
lute monocyte counts and the serum lysozyme. Males had slight
ly higher serum lysozyme than females and a gradual increase
in serum lysozyme was observed with increasing age.
Cohn and Hirsch (32) used ultracentr ifugat ion to sepa
rate and analyze the subcellular elements of rabbit polymor
phonuclear leukocytes. They found that 50^ of lysozyme was
found in the formed cytoplasmic granules and that the other
50^ was unbound and free in the cytoplasm. 3y preparing an
antibody to rat kidney lysozyme and tagging it with a fluo
rescent label, Glynn and Parkman (83, 8k) observed that the
label was about equally distributed between granules and cy
toplasm in rat polymorphonuclear leukocyte granules. When
-3
heat-killed E. coli were added to these granulocytes, the
granules were observed to coalesce into large br irnt-stain-
ing areas. Parkman (35) labelled the bacteria and by double
fluorescent studies concluded that the lysozyme was surround
ing the bacteria within cytoplasmic vacuoles.
Work has been done to correlate lysozyme with leuko
cyte turnover. Finch and associates (36, 87, 88) studied
serum lysozyme in various hematologic disorders. They found
elevated levels in acute monocytic leukemia, acute myelomono-
cytic leukemia, and acute and chronic granulocytic leukemias.
However, there were usually lower than average values in
acute and chronic lymphocytic leukemias. Elevated lysozyme
levels were also found in polycythemia vera, myeloid meta
plasia, and granulocytosis (infection). Below normal values
were found in agranulocytosis and aplastic and hemolytic
anemias. The conclusion was made that a valid positive rela
tionship existed between serum lysozyme and granulocyte turn
over rate.
Different investigators have used various methods for
altering intracellular and scrum lysozyme in the experimental
situation. Myrvik (39) demonstrated that the amount of lyso
zyme present in alveolar macrophages of rabbits could be
greatly increased by causing granulomatous lung disease in
duced by BCG innoculation. Cohn and Weiner (90, 91) found
increases in all hydrolytic lysosomal enzymes studied fol
lowing BCG stimulation. Carson and Donnenberg (92) hypo-
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thesized that lysozyme might work synergistically v/ith other
agents in tuberculous infection. However, although they ob
served increased lysozyme levels in macroohas-es of animals
treated with heat-killed Mycobacterium tuberculosis, they
could not demonstrate changes in protease or lipase content.
It has been found that various substances injected
into experimental animals will disrupt leukocytes with con
sequent release of lysozyme. Kerby (9", 9k) measured in
creases in lysozyme as a function of leukocyte injury by
various bacterial derivatives. Ribble (95 96) followed
increases in plasma lysozyme activity after injecting rab
bits with typhoid vaccine. He found that lysozyme activity
increased 200$ within two hours after injection, during which
time the rabbit became leuKopenic. The increase in serum
lysozyme was directly proportionate to the degree of leuko
penia. However, if the animals had been pretreated with
nitrogen mustard, there was no rise in serum lysozyme after
typhoid vaccine was administered. Similarly, there was no
elevation if the animals were made tolerant to the vaccine.
Changes in serum lysozyme, properidin, and white
blood counts after treatment of rats with x-irrad iation ,
zymosan and endotoxin were studied by Hook et al (97).
After 600 to 800 r of whole body x- irradiation, serum lyso
zyme fell to 20$ of normal values. Serum lysozyme levels
fell rapidly and remained low for 2k hours after the intra
peritoneal injection of zymosan. With endotoxin, there was
JO
a slight initial rise in serum lysozyme, followed by a fall
to subnormal levels for the next k8 hours. It was concluded
that lysozyme was a good index of cellular injury to white
blood cells caused by irradiation and endotoxin.
A guinea pig antiserum to rabbit leukocyte lysosomes
was prepared by Cuie and Hirsch (98). 'When this was added
to intact granulocytes, approximately SOh' of the enzymes,
including lysozyme, which were experimentally obtainable
by other methods, were released.
Glucose metabolism through the hexose monophosphate s hunt
The discovery by 'Warburg (99) in 1931 of the oxidation
of glucose-6-P to 6-phosnhogluconate established the existence
of a new reaction in glucose metabolism which differed from
the Embden-Meyerhof (EM) pathway. In the following decade,
the studies of 'Warburg, Lipmann, Dickens, Dische and others
demonstrated that phospno-gluconate is decarboxylated to COo
and a pentose phosphate, which is then reconverted to a
hexose phosohate. The detailed mechanism of this "hexose
monophosphate shunt" (HMS) was not elucidated until much
later, between 1950 and 1955, by Cohen, Packer, Horecker
and their coworkers (100).
The HMS encompasses a series of reactions that include
a number of novel transformations and compounds as well as
several of the intermediates and enzymes encountered in
glycolysis. It is in effect a multicyclic process whereby
3 molecules of glucose-6-phosohate give rise to 3 molecules
of CO2 and 3 five-carbon residues. The latter are rearranged
1*
to regenerate 2 molecules of glucose-6-phosohate and 1 mole
cule of glyceraldehyde-3-phospnate . Since two molecules of
glyceraldehyde-3-phosphate can regenerate a molecule of glu
coses-phosphate by reactions which are essentially a rever
sal of glycolysis, the pathway can account for the complete
oxidation of glucose independent of the citric acid cycle.
As in the E-M glycolysis pathway, oxidation is achieved by
dehydrogenation. However, in the case of the shunt pathway,
NADP and not NAD is used as a hydros-en acceptor. It is,
therefore, the important -'enerator of NADDH necessary for
synthesis of fatty acids a-d the functioning of various
hydroxylases. It also serves as a source of h-ribose as
well as of k-car,hon and 7-carbon sugars. Commencing with
glucose-6-phosphate , there is no further requirement for
ATP. The enzymes of the shunt pathway are found in the
extramitochondrial soluble portion of the cell, (101).
It is clear that the HMS is markedly different from
the E-M pathway of glycolysis. Oxidation occurs in the
first reactions, and C02* which is not produced at all in
the EtH pathway itself, is a characteristic product. This
fact has been utilized in experiments designed to evaluate
the relative proportions of glucose metabolized by the E-M
pathway compared with the shunt pathway. In 1953, 31oom
et al (102, 103) initiated the first use of specific illy
^C-labeled glucose to measure the relative amount of glucose
metabolized by the HMS and the E-M pathway. They measured
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the yield of 1^C in COp produced from glucose -] -1^C an3
glucose-6- ^C by tissue slices prepared from different
organs in rats. In the glycolytic pathway, carbons 1 and
6 of glucose are both converted to the methyl carbon of
pyruvic acid and are, therefore, metabolized in the same
manner. In the HMS, carbons 1 and 6 of glucose are treated
differently, carbon 1 being removed early by decarboxylation
with the formation of labeled CO2. 'With liver, Bloom e_t al
observed that there was a much greater yield of -^hcOp from
glucose-1- ^C than from glucose-6-lnC , and they concluded
that in liver the pentose pathway accounted for at least 607'
of the CO2 formed from glucose. This finding aroused much
interest because up to that time it had been considered that
the majority of carbohydrate metabolism occurred via the E-M
pathway and Krebs cycle. Shortly thereafter, investigators
in the laboratories of Weinhouse, Chaikoff, Cheldelin and
Wang published similar studies and the use of the yield of
l4c in fatty acids and other products was soon introduced as
a means of measurement (10k, 105, 106, 107).
In mammalian striated muscle, there appears to be no
glucose oxidation via the HMS, and catabolism proceeds en
tirely via glycolysis and the citric acid cycle. However, the
shunt is active in adipose tissue, adrenal cortex, thyroid,
testis, lactating mammary gland, and leukocytes (see Discussion
for activity of HMS in leukocytes). The special advantages
that accrue to the organism by virtue of the HMS, other than
pentose formation for nucleotide synthesis, appear to derive
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from the fact that no additional ATP is recuired, there is
no dependence upon the availability of the k-carbon dicar-
boxylic acids of the citric acid cycle, and, probably most
significant, this pathway employs NADP as the exclusive
electron acceptor. It is not clear whether ATP can be ef
ficiently formed by mitochondrial oxidation of NADPH produced
in the cytoplasm, but to the extent that this does occur, it
would hQ^mit generation of 3 moles of ATP per TPNH formed or
36 moles for the total combustion of glucose. This value
compares favorably with the yield of ATP from glycolysis
and the citric acid cycle. However, it appears likely that
most of the NADPH generated by the HMS is employed as a
reducing agent, particularly in the synthesis of fatty acids
and steroids. This is consonant with the distribution of the
enzymes concerned with these processes. Liver, lactating
mammary gland, testis, and adrenal cortex are active sites
of fatty acid and/or steroid synthesis, whereas these processes
are not prominent in the metabolism of striated muscle tissue
in which the HMS is not known to occur. In those cells in
which HMS oxidation is possible, it appears that the rate-
limiting factor is the availability of NADP, thus indicating
a coupling of glucose oxidation with the requirements of





Erlenmeyer flasks and syringes were siliconized when
total leukocytes were being obtained, but not when only
lymphocytes were desired.
2. Subjects
All experiments were performed on minimally hepa-
rinized fresh human venous blood (k. U.S. P. units of heparin
per ml of whole blood) obtained from healthy adult volunteers.
Subjects were divided into P.P.D. positive or negative groups
by presence or absence of induration measuring 10 mm or over
at the site of the intracutaneous injection of 0.1 ml of
Intermediate Strength, 5 U.S. units (TU), Tuberculin Purified
2
Protein Derivative (109,110) .Certain individuals were re-
tested with Second Strength, 250 U.S. units (TU) after a
negative reaction, and were discounted from either group after
a positive reaction, since only strongly positive subjects
were desired.
Sodium Heparin, 1,000 U.S. P. units per ml, from
intestinal mucosa, Upjohn Company.




Old tuberculin (OT) obtained from the Massachusetts
3
Department of Public Health (Lots 50 and 50c) contained
2,000 mg OT per ml and was bottled in pyrogen-free glassware
(111, 112). It was diluted with sterile normal saline to
1:20, giving a concentration of 100 mg per ml.
1+ . Tuberculin Purified Protein Derivative
Second Strength Tuberculin Purified Protein Derivative
containing 250 U.S. units (TU) per 0.1 ml or 0.05 mg PPD
per ml (as described in Section 2) was used undiluted.
5. Phytohemagglutinin
Bacto-Phytohemagglutinin-P (PHA-P) (5 ml per vial)
was obtained from Difco Laboratories, Detroit, Michigan,
and was diluted a further 20 times (113) before use.
6. Modified Krebs -Ringer phosphate buffer (KRP)*+
KRP buffer pH 7.1+ was modified to contain one-fifth
of the suggested concentrations of CaCl2 and MgS0[. (to
prevent precipitation) (Ilk)- Four units of heparin were
added per ml of buffer.
^Supplied through the courtesy of Dr. Elisha Atkins,
Yale University School of Medicine, New Haven, Connecticut.
^Supplied through the courtesy of Dr. Phyllis Bodel,
Yale University School of Medicine, New Haven, Connecticut.
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7. Heparinlzed buffered tissue culture medium
Minimum Essential Medium (Eagle) with NaHCOo (35 ml
of 5.6% sterile sodium bicarbonate solution for each 100 ml
of medium) was stored at 1+ C. Four units of heparin were
added per ml of medium. Before use, CO2 was run through the
medium for 3 minutes to obtain a pH of approximately 7.1+.
During experimentation, flasks containing; medium were tightly
sealed with parafilm.
8. Leukocyte Suspension
Total leukocyte counts from each 50 ml or 100 ml
blood sample were done in a "Coulter counter" and 100
leukocytes were differentiated on Wright's stained blood
smears made on cover glass. White blood counts (WBC) ranged
from 6,000 to 10,000 cells per cu mm with lymphocytes usual
ly making up 25-35 per cent of the total.
Two methods were used to remove red blood cells from
whole blood:
a. Sedimentation
Red blood cells were settled by allowing
the heparinlzed whole blood to stand 90 minutes
at room temperature. The supernate was then
pipetted off using a standard Pasteur pipette.
5supplied through the courtesy of Dr. Phyllis Bodel,
Yale University School of Medicine, New Haven, Connecticut.
'Flow Laboratories, Inc., Rockville, Maryland.
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b. Centrifugation
The heparinized blood was placed in centri
fuge tubes and spun at (kO X g) for 10 minutes
at k0. The supernate was then pipetted off as
in method a.
WBC and differential were done on the supernate
resulting from either method and the supernate was then
spun at (600 X g) for 15 minutes. The plasma was removed
and respun at (1,000 X g) for 20 minutes. The cell-free
supernate was saved for resuspension of the cell button in
various experiments (see Experimental Procedures).
9 . Separation of lymphocytes by nylon column (115)
7
The nylon columns were made by preparing Dupont
nylon and putting 0.7 g of it into a standard Pasteur
pipette. The preparation of the nylon consisted of washing
it by weighing 250 mg of nylon in i+ liters of water with kO
ml of Dupinol. It was then rinsed in tap water and heated
from 65 to 70 for 30 minutes. It was washed in tap water
overnight and rewashed with distilled water 7 times and
then air-dried. The dried, washed nylon was then combed
with a nylon comb and brushed to remove any lumps or snags.
The column held approximately 1.75 ml.
The column was wetted with heparinized buffered tissue
'Obtained through the courtesy of Dr. Fred Kantor,
Yale University Scnool of Medicine.
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culture medium (see section 7) from a 3 cc syringe, noting
the volume used. The cell button obtained f rom 100 ml of
whole blood was resuspended in 0.2 ml of cell-free auto
logous plasm (see section 8) and 1.3 ml of heparanized
buffered tissue culture medium. This concentrated leukocyte
suspension was then slowly injected into the column and the
replaced wetting medium was discarded. The column was then
allowed to stand 25 mihutes at room temperature, after which
2.0 ml of medium were slowly injected into the column while
catching the lymphocytes suspended in approximately 0.2 ml of
plasm and 1.8 ml of medium. The final differential usually
indicated greater than 90$ lymphocytes. The average yield
of this procedure was 7.5 X 10' lymphocytes from a starting
sample of 100 ml of blood.
10. ^C0 assay for measuring glucose-1- ^-C oxidation
Glucose-1-^C oxidation was measured by assaying ^kC02
production according to a modification of the technique de
scribed by De Chatelet, Cooper and McCall (116).
Whole blood, leukocyte suspensions or controls to be
assayed were prepared in triplicate siliconized 25 ml
Erlenmeyer flasks to a total volume of either l+0 or 6.5 ml
as described below (see Experimental Procedures). Included
Ik ft
in the total was either 0.1 or 0.2 ml glucose-1- ^0 (specific
New England Nuclear Corporation, Boston, Massachusetts
2k
activity: 51+.2 mCi per ramole. The isotope was dissolved
in normal saline to give a concentration of 2 mcCi per ml
and stored frozen. Each flask was stoppered and fitted with
q
plastic well-sticks into which 0.2 ml of hydroxide of
hyamine was introduced with a syringe and needle. The flasks
were then incubated in a shaking water bath at 37 C for a
specified length of time (see Experimental Procedures). At
the end of this period, 1.0 ml of 5 N H2S0r was added by
syringe and needle to the contents of the flask to stop the
reaction and release ^C02. Gentle agitation at 37 C was
then resumed for an additional 30 minutes in order to trap
^C02 in the hyamine. Radioassay of the ^"C02 in hyamine
was done in a liquid scintillation counter using Bray's
solution as a counting fluid. Counting was done for 10 min
and the values obtained were divided by 10 to give counts
per min. Results were expressed as the average of the counts
of the three flasks.
11. Lysozyme assay
Plasma lysozyme activity was measured by the turbidi-
metric method of Smolelin and Hartnell (117) with the modi
fication of Litwack (118}. The lysozyme activity of an
aliquot of frozen serum from a single normal donor along with
that of a known concentration of hen-egg white lysozyme were
Kontes Glass Company, Fireland, New Jersey.
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used to standardize and control each series of unknown deter
minations. Values were expressed as micrograms (meg) of
egg-white lysozyme activity per ml of plasma.
12. Experimental Procedures
Five groups of experiments were performed. They are
each given a Roman numeral which they will retain through
other sections for easier cross-referencing.
I In order to compare the glucose-1- ^C oxidation
of isolated leukocytes from PPD positive sub
jects and that of leukocytes from PPD negative
subjects after incubation with OT for 2 hours at
37 C, triplicate 25 ml Erlenmeyer flasks were
prepared according to Table 1,
The cell buttons obtained from 50 ml of whole
blood from a PPD positive and a PPD negative sub
ject were resuspended to k X 10' leukocytes per
0.5 ml of autologous plasma (see section 8).
Glucose-l-^^C oxidation was determined by ^C02
assay (see section 10). Four positive and four
negative subjects were used.
Table 1 on following page.
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Table 1
Protocol for Glucose-1-1^ Oxidation Study
in Comparison Between
Leukocytes from PPD Positive and Negative Subjects
After Incubation with OT for 2 Hours
Components PPD Positive PPD Negative Control
Subject Subject
Number of Leukocytes k X 10^ k X 10?
Plasma 0.5 ml 0.5 ml
Old Tuberculin 0.5 ml 0.5 ml 0.5 ml
(1:20; 100 mg/ml)
Heparinized 2.9 ml 2.9 ml 3.1+ ml
KRP buffer
Glucose -l-^C 0.1 ml 0.1 ml
(0.2 racCi/0.1 ml)
0.1 ml
Total k0 ml k.O ml k.O ml
II In order to measure glucose-1- ^C oxidation of
whole blood from 1+ PPD positive and 1+ PPD nega
tive subjects after incubation for 2 hours with
0T, PPD, or saline, triplicate 25 ml Erlenmeyer
flasks, again containing a total volume of k0
ml, were prepared.
Twelve flasks, each containing 0.2 ml of glucose-
1- % and 3.3 ml of whole blood from a PPD positiv
subject and a duplicate group of flasks with blood
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from a PPD negative subject were allowed to in
cubate as previously described (see Section 10)
for 1 hour. At the end of this period, 1.0 ml
of 5 N H2S0r was injected into a set of 3 flasks
from each group in order to stop the reaction.
The remaining sets of flasks from each group re
ceived 0.5 ml of OT (1:20 or 100 mg per ml),
0.5 ml of PPD (1:1 or 0.05 mg per ml), or 0.5 ml
of N saline and were allowed to incubate for an
additional 2 hours. At this time, the remaining
reactions were stopped and ^C0p was assayed.
Ill Lysozyme levels were used as an indicator of
leukocyte stimulation after simultaneous incuba
tion of whole blood from a PPD positive and a PPD
negative subject with 0T for 1, 3> 5 8, and 21+ hours.
Five ml of whole blood from a PPD positive subject
and 0.5 ml of 0T (1:20 or 100 rag per ml) were
added to each of fifteen 25 ml Erlenmeyer flasks.
A duplicate group of flasks containing blood from
a PPD negative subject was simultaneously tested.
Triplicate sets from each group were allowed to
incubate in a shaking water bath at 37 C for 1, 3,
5, 8, and 21+ hours. Triplicate baseline flasks
containing 5 ml of whole blood and 0.5 ml of N saline
were prepared for each group. At the end of each
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period, the contents of the flasks were centri
fuged at (1,000 X g) for 20 min, and the super
natant cell-free plasma was assayed for lysozyme
(see section 11). Assays were also performed on the
baseline plasmas. Six different subjects were used.
TV -"k^ assay was done on whole blood from PPD posi
tive subjects after incubation for 2 hours with
lymphocytes stimulated with 0T, with unstimulated
lymphocytes, or with 0T and medium without lympho
cytes. The experiment consistes of two parts.
STEP 1
The cell button obtained by centrifugation
(see section 8) of 100 ml of whole blood from a
PPD positive subject was resuspended in 0.2 ml of
cell-free autologous plasma and 1.3 ml of hepari
nized buffered tissue culture medium for separation
of lymphocytes by nylon column (see Section 9).
The resulting suspension of lymphocytes in 0.2 ml
of plasma and 1.8 ml of medium was added to k8 ml
of plasma and 13.2 ml of medium. Ten ml of this
final suspension were placed in f lask "A" to which
0.5 ml of 0T (1:20 or 100 mg per ml) was added. The
remaining 10 ml were placed in flask "B" to which
0.5 ml of N saline was added. Flask "C" was prepared
by adding 0.5 ml of 0T to 2.5 ml of plasma and 7.5 ml
of medium (without lymphocytes). After running C0?
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through them for 3 min and sealing them tightly
with parafilm (see section 7), the 3 flasks were
incubated in a shaking water bath at 37C for 21+ hours
Step 2
At the end of this period, 50 ml of blood
were obtained from the same donor as in Step 1
and triplicate 25 ml Erlenmeyer flasks were pre
pared according to Table 2 for '^kOp assay after
2 hours of incubation (see section 10). Three
positive subjects were used.
Table 2
Protocol for Glucose-1- ^"C Oxidation Study
of Whole Blood after Incubation for 2 Hours
with OT-stimulated and Unstimulated Lymphocytes and Control
Components Set 1 Set 2 Set 3
Whole blood from same 3*3 ml 3*3 ml 3.3 ml
donor as in step 1
Flask "A" 3.0 ml
Flask "B" 3.0 ml
Flask "C" 3.0 ml
Glucose-l-^C 0.2 ml 0.2 ml 0.2 ml
in normal saline
(0.2 mcCi/0.1 ml)
Total 6.5 ml 6.5 ml 6.5 ml
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V ^"002 assay was again performed on whole blood
from PPD positive subjects. However, this time,
the 2 hour incubation was carried out with lympho
cytes stimulated with PHA, with unstimulated lym
phocytes, or with PHA and medium without lympho
cytes.
A procedure identical to that in IV was used
except that 1.0 ml of phytohemagglutinin was
added to flasks "A" and "C" instead of 0.5 ml
of OT, and 1.0 ml instead of 0.5 ml of N saline





The design and results of experiments are summarized
in tabular form. In each case, results are expressed as the
average of triplicate flasks. In experiment I, independent
t-test analysis was done. In experiments II, III, IV, and V,
where the subject served as his own control, the data were
processed by paired t-test analysis.
Experiment I
A comparison was made between the glucose-1- ^"C
oxidation of leukocytes from PPD positive subjects and that
of leukocytes from PPD negative subjects after incubation
with OT for 2 hours. Table 3 indicates the results of k
separate experiments. Because the leukocyte concentration
was adjusted in each case to l| X 10' cells per ml, the PPD
positive group could be compared directly to the PPD negative
group. The average counts per min were 21,695 - l*lk0
(mean - S.E.M.) for the PPD positive group and 20,961 8,900
for the PPD negative group. No significant difference could
be found between the two groups (p greater than 0.5).
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Table 3
Comparison between Glucose-1- C Oxidation of
Leukocytes from PPD Positive and Negative Subjects
after Incubation with OT for 2 Hours






Mean S.E.M. 21,695 - 1,11+0 20,961 8,900
Comparison of (A) and (B) t = 0.5062
P > 0.5
Experiment II
Measurements were made of glucose-1- ^"C oxidation of
whole blood from PPD positive and PPD negative subjects after
incubation for 2 hours with 0T, PPD or saline. The results of
1+ tests are indicated in Table 1+. The number of counts In the
2 hours of incubation with antigens or saline was determined by
subtracting the number of counts in the reaction without anti
gens or saline stopped at one hour from the counts obtained in
the reactions stopped at three hours, the first hour being with
out and t he next two hours being with antigens or saline (see
Experimental Procedures II). Since whole blood was used, the
number of leukocytes naturally varied in each sample and average
counts per min would be meaningless. Each person, therefore,




Glucose-l-1^! Oxidation of Whole Blood
from PPD Positive and PPD Negative Subjects









1 2,228 2,111 2,196
2 k,126 l+,559 5,210
3 2,358 2,517 2,891
1+ 3,023 3,190 3,2k5
Comparison of (A) and (B) t = 1.8327
p > 0.1
Comparison of (A) and (C ) t = 0.1015
P > 0.3
PPD Negative Group
(D) Saline (E) PPD (F) 0T
(Counts/min) (Counts/min) (Counts/min)
1 l+,I+82 3,693 3,2k9
2 2,676 1,981+ 3,33k
3 2,881 3,532 3,51+1
k k,l+79 3,768 3,927
Comparison of (D) and (E) t = 1.1211
P > 0.3
Comparison of (D) and (F) t = 0.2231
p >0.8
3k
No significant difference could be found in the PPD
positive group between the flasks with OT and those with
saline (p_>0.1), nor between those with PPD and those with
saline (p.>0.3). The same was true for the PPD negative
group, where no significant difference existed between the
flasks with OT and those with saline (p>0.3), nor between
the flasks with PPD and those with saline (p>0.8).
Experiment III
Lysozyme production was used as an indicator of
leukocyte stimulation after simultaneous incubation of whole
blood from a PPD positive and a PPD negative subject with
OT for 1, 3, 5, 8 and 2k hours. Results are given in
Table 5 Again subjects served as their own controls by
comparing results at different lengths of incubation with
baseline values. The per cent increase of lysozyme produc
tion was only determined for results with statistical signi
ficance by dividing the incubation value In excess of the
baseline value and multiplying by 100. No significant
difference was found in the PPD negative group at any incu
bation time: p>0.9 at 1 hour, p>0.l+ at 3 hours, p;>0.6 at
5 hours, p>0.2 at 8 hours, p>0.1 at 2k hours. However, in
the positive group, statistical significance was not seen at
1 hour (p>0.1), but was observed starting at 3 hours where
per cent increase was 1
- 0.9$ (mean - S.E.M.) (p<0.05). Per
cent increase was 10 - l\.% (p<0.02) at 5 hours, 19 - $% (p<0.02)
at 8 hours, and 112 32$ (p<0.02) at 2k hours.
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TABLE 5
Lysozyme Production of Whole Blood
From PPD Positive and Negative Subjects













1 15.5 15.7 16.0 3 16.2 5 17.0 10 21).. 0 61
2 3.8 14-.3 1+.3 1 k.5 18 k.8 26 10. k 17k
3 6.5 6.3 6.5 0 7.0 8 7.8 20 16.8 100




















1 h 3 h 5 h 8 h 2k h
1 8.2 8.5 8.8 9.3 9.5 10.0
2 6.8 6.8 7.3 7.6 7.8 7.5















Figures 1, 2, and 3 depict the graphs of the results of
the enree individual experiments. In figure 1, there was clearly
a rise in the curve between 8 and 2k hours for the PPD positive
subject, while the curve of the PPD negative subject remained
fairly flat. In Figure 2, although the baseline value for the
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Figure 1: Comparison of lysozyme production of whole
blood from a PPD positive and a PPD negative









O PPD POSITIVE SUBJECT (2)






Figure 2: Comparison of lysozyme production of whole
blood from a PPD positive and a PPD negative




PPD POSITIVE SUBJECT (3)






Figure 3s Comparison of lysozyme production of whole
blood from a PPD positive and a PPD negative
subject after incubation with OT.
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by the end of 21+ hours the amount of lysozyme was greater
in the PPD positive sample. This again occurred in the
experiment depicted in Figure 3*
Experiment IV
1^C02 assay was done on whole blood from PPD positive
subjects after incubation for 2 hours with lymphocytes stimu
lated with OT, with unstimulated lymphocytes, or with OT and
medium without lymphocytes. The results of these tests are
included in Table 6.
Table 6
Glucose-l-^C Oxidation of Whole Blood after Incubation for 2 Hours
with OT-stimulated and Unstimulated Lymphocytes and Control
(A) Stimulated (B) Unstim. $ (C) Control $
Subject (Counts/min) (Counts/min) Incr. (Counts/min) Incr.
1 10,528 2,029 1+19 1,501 601
2 16,280 6,293 159 5,572 192
3 13,179 2,211 k89 2,372 k62
Mean t S.E.M. 356 t 101 1+18 121
Comparison between (A) and (B) t
= 13.712
p < 0.01
Comparison between (A) and (C) t
= 17.553
p < 0.01
Comparison between (B) and (C) t
= 1.31+9
P > 0.1
The per cent increases of
CO production were obtained in
each case by dividing the stimulated value in excess
of the
unstimulated value and in excess of the control value by the
unstimulated value and the control value respectively, and
l+o
multiplying by 100. No significant difference was found
between the unstimulated values and the control values
(p>0.1). However, the blood incubated with stimulated lympho
cytes showed an increase of 356 101$ (p<0.01) in glucose-1- C
oxidation above the blood incubated with unstimulated lympho
cytes. Similarly, there was an increase of kl8 121$ (p<0.01)
above the control values.
Experiment V
lkC02 assay was again done on whole blood from PPD
positive subjects. However, in this case the 2-hour incuba
tion was carried out with lymphocytes stimulated with PHA,
with unstimulated lymphocytes, or with PHA and medium without
lymphocytes. Results of 3 tests are given in Table 7.
Table 7
Glucose-1- C Oxidation of Whole Blood after Incubation for 2 Hours
with PHA-stimulated and Unstimulated Lymphocytes and Control
(A) Stimulated (B) Unstim. $ (C) Control $
Subject (Counts/min) (Counts/min) Incr. (Counts/min) Incr.




Comparison between (A) and (B) t
= 71.213
p ( 0.001
Comparison between (A) and (C) t = 38.520
p < 0.001









The per cent increases were obtained in the same manner
as in experiment IV. As in that experiment, no significant
difference was observed between the unstimulated values and
the control values (p>0.5). Blood incubated with stimulated
lymphocytes again showed an increase in glucose-1- C oxida
tion over blood incubated with unstimulated lymphocytes or
with antigen and medium without lymphocytes. There was an
increase of kl8 - 36^ (p<0.001) above the unstimulated value





Glucose oxidation in polymorphonuclear leukocytes
has been shown to be stimulated by the act of phagocytosis
(119) and by the administration of certain membrane-active
agents (120). It was of interest to determine whether this
aspect of polymorphonuclear leukocyte metabolism might be
affected by lymphocyte-induced stimulation. In experiments
IV and V, it can be seen that glucose-l-1kc oxidation was
dramatically increased in the g roup incubated with stimulated
lymphocytes as compared to the group incubated with unstimu
lated lymphocytes. The average increase in ^"COp production
in the group incubated with specifically stimulated lympho
cytes, i.e., with OT, was 356 - 101$ of the group incubated
with unstimulated lymphocytes. Similarly, there was an av
erage increase of l\.lQ - J>6% in the group incubated with non
specif ically stimulated lymphocytes, i.e., with PHA, over
the group incubated with unstimulated lymphocytes.
However, because, as was stated previously, oxida
tion of glucose is increased during phagocytosis, it was
necessary to determine whether significant amounts of
phagocytizable matter might have formed during the 2k-hour
incubation. It was also important to confirm that OT and
PHA did not in themselves produce a stimulatory effect on
a3
kC02 production in 2 hours of incubation, ~n test these
two possibilities, media and antigen were incubated for
2k hours and then added to whole blood for 2 hours before
^C02 assay. These control flasks exhibited the same
unstimulated rate of glucose-10 oxidation as the flasks
incubated with unstimulated lymphocytes.
The fact that little, if any, stimulation of glucose
utilization is produced by the antigen itself in the first
two hours of incubation of whole blood was confirmed in
experiment II. No significant difference in glucose utili
zation was found in either the PPD positive or the PPD
negative groups between blood incubated with OT or PPD and
blood incubated with saline. Similarly, in experiment I,
no significant difference in glucose utilization was found
between a fixed number of leukocytes from PPD positive
subjects and those from PPD negative subjects after incuba
tion with OT for 2 hours.
Further studies concerning the time factor involved
in activating the lymphocyte before it can exert its effect
on polymorphonuclear leukocytes were carried out in experi
ment III. In the PPD positive group, no significant in
crease in lysozyme production over baseline values could
be seen after incubation with OT for 1 hour. Howver, after
3 hours, there was a slight but significant increase (1.0 - 0.9."!)
which became larger after 5 hours (10 - k$) after 8 hours
(19 * 5$) and markedly after 2k hours (112 32*). The
kk
fact that this increase was not due to the effect of the
antigen on the polymorphonuclear leukocytes themselves can
be seen in the lack of increase in the PPD negative group.
Two classes of materials have previously been mentioned which
stimulate leukocyte oxidation. These are pnagocytizable
particles (121). and certain membrane-active substances which
may stimulate pinocytosis (122), such as endotoxin, deoxy-
cholate, digitonin (123), and dilute anti-macrophage serum
(12k, 125). However, these materials act very quickly upon
being introduced into the leukocyte culture. Therefore, the
activation of lymphocytes mentioned above appears to act by
a different mechanism, one involving prolonged intracellu
lar processes. However, once these processes are underway,
the lymphocytes exert their action on polymorphonuclear
leukocytes quickly as evidenced by the rapid (2 hour) increase
in glucose utilization in experiments IV and V. This latent
period is interesting, especially in light of the fact that
a period of 2 to 3 days was sometimes found by Mackaness
(126) to be required for the development of enhanced non
specific bactericidal capacity in mouse peritoneal macrophages.
For example, macrophage bactericidal capacity was enhanced
only 2 to 3 days after normal mice received Bacille Calmette-
Cuerin (BCG) plus lymphocytes from BCG-immunized donors.
The question might be raised as to how much is con
tributed by the added stimulated lymphocytes themselves to
the increase in glucose utilization. As described in the
k5
Review of Literature, specifically ^C-labeled glucose is
used in the estimation of HMS activity. In 1956, Kits (127)
reported that in splenic and thymic lymphocyte preparations,
the HMS is operative as evidenced by experimental findings
using ^"C specifically labeled glucose as substrates. How
ever, Beck (128) has estimated, on the basis of findings in
enzyme studies with white blood cell homogenates, that approxi
mately 3$ of the glucose utilized was by way of the HMS.
MacHaffie and Wang (129) reported that radiorespirometric
experiments with C specifically labeled glucose as substrate
demonstrated that glucose is utilized by intact lymphocytes
predominantly by way of the glycolytic pathway, leading to
the formation of lactate and pyruvate. Their results also
revealed that the HMS is playing a rather minor role in being
responsible for the utilization of not greater than 2$ of the
catabolized glucose. More recently, it was shown by MacHaffie
and Wang (130) that the glucose metabolism in intact lympho
cytes was found to be altered in the presence of phytohemag
glutinin. The operation of the HMS and, to some extent the
pentose cycle pathway in lympnocytes was found to be enhanced.
This finding was interpreted as reflecting an additional need
of biosynthetic intermediates and NADPH by the lymphocytes to
accommodate mitotic activity induced by phytohemagglutinin.
However, the activity of the HMS was still small in compari
son to the activity of the glycolytic pathway.
It is, therefore, assumed that the dramatically increased
k6
glucose-1- ^C oxidation in experiments IV and V must be due
to stimulation of some other element(s) in the whole blood.
Erythrocyte and platelet metabolism has not been shown to be
enhanced by stimulated lymphocytes, OT or PHA (13D. In the
red blood cell, both the E-M pathway and the HMS are active
(132). However, Murphy (133) calculated the CO production
in erythrocytes in experiments with C-labeled glucose and
showed that the portion of glucose transformed in the HMS was
only 5-10$ of the total utilized glucose. Similarly, DeLoecker
and Pranherd (13k) studied human red cells in phosphate buffer
with glucose-1- C and found that these cells utilized 20,6
microliters of O2 per ml of cells in 3 hours and 2,05 micro-
moles of glucose per ml of cells per hour, and produced kU
micromoles of lactate. From the COp produced, it was calcu
lated that only 8,5$ of the glucose was metabolized via the
HMS. The respiratory coefficient for thrombocytes is about
equal to unity (135, 136). However, experiments with ^C-glu-
cose have shown that exogenous glucose does not serve as the
principal substrate for oxidative metabolism in thrombocytes
(137). Glucose oxidation accounted for as little as 6-10$
of oxygen consumption. Respiration was largely independent
of sugar addition. Monocytes, eosinophils and basophils
are present in very small numbers in whole blood in compari
son to polymorphonuclear leukocytes, and their contribution
to glucose metabolism may be condidered negligible.
Furthermore, another parameter was used to indicate
k?
the stimulatory effect of sensitized lymphocytes, i.9., lyso
zyme production. As noted in the Review of Literature, a posi
tive relationship exists between serum lysozyme and both granu
locyte count and granulocyte turnover. However, lymphocytes
alone have little if any lysozyme activity.
Speculation can be made about the function of the in
creased glucose-1- C oxidation in polymorphonuclear leukocytes
incubated with activated lymphocytes. Although HMS activity
cannot be equated with glucose-1- ^C oxidation, the shunt does
play a major role in carbohydrate metabolism in the polymor
phonuclear leukocyte (see Review of Literature), Two biochemi
cal processes can be looked at, both of which utilize reduced
nicotinamide adenine dinucleotide phosphate (NADPH), which is
produced by the HMS, and regenerate its oxidezed form (NADP),
the level of which appears to regulate HMS activity (138).
The first process is synthesis of membrane lipids. In phago
cytosis, where plasma membrane is expended in the formation of
phagosomes and presumably regenerated, increased incorporation
of precursors into phospholipids has been demonstrated (139).
Similarly, the stimulation of HMS activity in macrophages
treated with migration-inhibitory-factor (MIF)-rich fractions
may reflect increased turnover or even net synthesis of mem
brane involved in locomotion (IkO), spreading and ruffled
border activity,
Ik
On the other hand, increased glucose-1- C oxidation
might be related to enhanced microbicidal capacity. Reduced
k8
pyridine nucleotides, possibly from the HMS, might be oxidized
to produce hydrogen peroxide (lkl, 1U2, lk3) Oee et al (lkk)
have reported hydrogen peroxide-generating mechanisms, the
activation of which increases during phagocytosis, in guinea
pig alveolar macrophages, while Paul et al (lk5) have made
similar observations with mouse peritoneal macrophages. In
addition, Cotran and Ditt (lk6) have reported endogenous
peroxidase in guinea pig peritoneal macrophages. Klebanoff (lk7)
has clearly implicated hydrogen peroxide with a peroxidase in
the bactericidal capacity of polymorphonuclear leukocytes.
One can speculate that stimulation of glucose-1- ^C oxidation
in polymorphonuclear leukocytes incubated with stimulated
lymphocytes may reflect activation of a peroxide-forming mecha
nism which is potentially microbicidal. Moreover, this micro
bicidal capacity would be enhanced by the increased lysozyme
production observed in experiment III.
Work with macrophages has already been done in this
area, Simon and Sheagren (lk8) have observed that when
whole peritoneal exudate cells taken from guinea pig3
sensitized to PPD or other protein antigens were incubated
with the sensitizing antigen for 2k hours, the resulting
macrophage monolayers killed Listeria monocytogenes much
better than the same cells incubated without antigen. Fur
thermore, the same workers have found that sensitive lymph
ocytes can confer this "immunity" on normal macrophages in
vitro, Patterson and Youmans ( 11+9 ) have reported that
k9
lymphocytes from M. tuberculosis-immunized mice, when cultured
in vitro with the same organism produced supernates which
inhibited the growth of this organism in normal macrophages.
This raises the question of the possible mechanism by which
the postulated lymphocyte stimulation of polymorphonuclear
leukocytes occurs.
The capacity of sensitized cells to affect a popula
tion of other cells may result from cell to cell contact or
indirectly through the release into the medium of a material.
Bloom and Bennett (150) have obtained evidence to support the
latter possibility. They studied migration using highly pu
rified populations of macrophages and peritoneal lymphocytes
from tuberculin-sensitive guinea pigs. They reached two
important conclusions: (1) sensitive lymphocytes are necessary
for inhibition of macrophage migration; (2) inhibition of
migration of normal macrophages can be accomplished by a cell-
free supernate of sensitive lymphocytes that have been incu
bated with specific antigen (PPD) for 2k hours. Furthermore,
David (15D has shown that inhibition of protein synthesis
prevents the specific inhibition of migration. The material
produced is now ordinarily referred to as MIF (migration in
hibitory factor). At about the same time, sensitized lympho
cytes were shown to be cytotoxic for cells to which the lym
phocytes had been specifically sensitized (152, 153). Al
though many studies have suggested that this cytotoxicity
was mediated directly by the lymphocytes, others have indi-
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cated that cytotoxicity could be achieved by soluble media
tors (15k, 155). Some investigators have also found that
stimulation of lymphocytes by antigen will cause them to
produce a soluble substance which causes non-sensitive lym
phocytes to divide (156, 157). The interaction of sensitive
lymphocytes with specific antigen has yielded soluble materi
als which have several other biological activities (158).
In addition to MIF, a cytotoxic factor and a blastogenic
factor, the following have been described: a factor which
causes reddening of the skin and infiltration by mononuclear
cells typical of the delayed reaction (159), a factor chemo-
tactic for macrophages (160) and a factor chemotactic for
polymorphonuclear leukocytes (161), a factor with interferon
activity (162), and factors which inhibit the growth of cul
tured cells without killing them (163, 16k ) . However, for
the most part, what has really been demonstrated is a number
of different activities. It is unlikely that each of the
activities separately identified is actually a function of a
distinct substance. Therefore, it can be speculated that
still another substance is produced by activated sensitized
lymphocytes which stimulates polymorphonuclear leukocytes as
11+
evidenced by increased glucose-1- C oxidation and production
of lysozyme, or that one of the already existing "factors"
has this additional effect.
The fact that stimulation of polymorphonuclear leuko
cytes occurred when they were incubated with lymphocytes ac-
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tivated by a specific antigen, i.e., OT, and also with lym
phocytes activated by a so-called non-specific agent, i.e.,
PHA, is noteworthy. An important question asked is whether
when a lymphocyte is activated, it is in effect "turned on"
for everything it is capable of making regardless of the
conditions, or whether there are circumstances when this is
selective and only certain a ctivities are released. Recent
ly, it has become evident that lymphocytes can be activated
by a nonimmunologic stimulant, such as a mitogen, to produce
soluble substances with activities similar to those stimulated
by specific antigen. In early in vitro studies, Granger and
Kolb (165) provided strong indications that destruction of
target L cells by either immune or PHA-stimulated normal
mouse lymphocytes was not the direct result of aggressor-
target cell contact, but was instead associated with lym
phocyte activation and consequent secretion by lymphocytes
of a soluble non-specific cell toxin. Pick e_t al (166) have
described mitogen-induced release of MIF and skin reactive
factor. The results of this present study indicate that both
with specific stimulation with OT and non-specific stimula
tion with PHA, lymphocytes have produced what appears to be




Reactions of cellular hypersensitivity often involve
the participation of different cell types. The communication
between lymphocytes and polymorphonuclear leukocytes was in
vestigated. Human sensitized lymphocytes exposed to old tu
berculin were found to have a stimulatory effect on polymor
phonuclear leukocytes as indicated by the latter' s increased
glucose-1- ^C oxidation and lysozyme production. Similar
results were obtained using lymphocytes non-specif ically
stimulated by phytohemagglutinin. Activation of lymphocytes
required a latent period (2k hours) followed by rapid stimu
lation of polymorphonuclear leukocytes (2 hours). These re
sults suggest that Increased glucose-1- ^C oxidation and ly
sozyme production may be related to enhanced microbicidal
activity. A possible mechanism by which the postulated lym
phocyte stimulation of polymorphonuclear leukocytes occurs
is the secretion into the medium by the sensitized lympho
cytes of a soluble substance which has biological activity.
This activity may be due to a new material or it may be a
function of one of the already described lymphocyte "factors".
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